OpenAI Relaunches ChatGPT Health with Apple Health Integration for All US Users

OpenAI is relaunching Health in ChatGPT, the feature that connects to Apple Health on iPhone, with expanded access to all logged-in US users 18 and older. The rollout spans web and iOS across Free, Go, Plus, and Pro subscription tiers, according to OpenAI.

The company originally piloted the feature in January 2026 to a limited group of testers. That initial version reportedly delivered lackluster results, according to early feedback, which coincided with the feature disappearing from public discussion for months. Today's relaunch marks a broader release built on lessons from that trial.

What's changing

"Health in ChatGPT is launching to U.S. users," OpenAI said in its announcement. Users can choose to securely connect Apple Health and supported medical records so ChatGPT can reference that information in conversations.

According to OpenAI, the updated feature can now:

• Compare new test results against prior tests
• Summarize changes since a user's last medical appointment
• Explore relationships between sleep, activity, and workout data

OpenAI attributes some of the improvement to broader upgrades to its frontier models made since the start of the year, though the company did not specify which models power the Health feature or provide any benchmark data tied to health-related accuracy.

Access details

OpenAI says it is "beginning to roll out Health to logged-in ChatGPT users 18 and older in the U.S. on web and iOS across Free, Go, Plus, and Pro plans today." Users can access the feature by opening Health from the ChatGPT sidebar. The feature is explicitly not available in Codex, OpenAI's coding-focused product.

No pricing changes were disclosed — Health appears to be included at no additional cost across all listed subscription tiers, including the Free plan.

What this means

This relaunch signals OpenAI's continued push into consumer health applications, a category where AI accuracy carries higher stakes than typical chatbot use cases. The company's silence following the January pilot — and its own admission that feedback was "lackluster" — suggests real technical hurdles in reliably interpreting health data, not just a slow rollout schedule.

Expanding to Free-tier users is notable: OpenAI could have restricted the feature to paid subscribers as a premium differentiator but chose broad access instead, suggesting the company sees health data integration as a strategic wedge for daily engagement rather than a monetization lever.

The integration also deepens OpenAI's reliance on Apple's Health ecosystem without any indication of a formal partnership or data-sharing agreement between the two companies — this is OpenAI building on top of Apple's existing HealthKit APIs, the same access point available to any third-party developer. Whether ChatGPT's health guidance proves reliable enough to earn user trust at scale remains unverified, and OpenAI has not published any clinical validation, accuracy benchmarks, or details on how the underlying models were evaluated for health-related use cases.